Circulating miRNAs as diagnostic biomarkers for adolescent idiopathic scoliosis
José Luis García-Giménez, Pedro Antonio Rubio-Belmar, Lorena Peiró-Chova, David Hervás, Daymé González-Rodríguez, José Santiago Ibañez-Cabellos, Paloma Bas-Hermida, Salvador Mena-Mollá, Eva María García-López, Federico V Pallardó, Teresa Bas, José Luis García-Giménez, Pedro Antonio Rubio-Belmar, Lorena Peiró-Chova, David Hervás, Daymé González-Rodríguez, José Santiago Ibañez-Cabellos, Paloma Bas-Hermida, Salvador Mena-Mollá, Eva María García-López, Federico V Pallardó, Teresa Bas
Abstract
The aetiology of adolescent idiopathic scoliosis (AIS) has been linked to many factors, such as asymmetric growth, neuromuscular condition, bone strength and genetic background. Recently, epigenetic factors have been proposed as contributors of AIS physiopathology, but information about the molecular mechanisms and pathways involved is scarce. Regarding epigenetic factors, microRNAs (miRNAs) are molecules that contribute to gene expression modulation by regulating important cellular pathways. We herein used Next-Generation Sequencing to discover a series of circulating miRNAs detected in the blood samples of AIS patients, which yielded a unique miRNA biomarker signature that diagnoses AIS with high sensitivity and specificity. We propose that these miRNAs participate in the epigenetic control of signalling pathways by regulating osteoblast and osteoclast differentiation, thus modulating the genetic background of AIS patients. Our study yielded two relevant results: 1) evidence for the deregulated miRNAs that participate in osteoblast/osteoclast differentiation mechanisms in AIS; 2) this miRNA-signature can be potentially used as a clinical tool for molecular AIS diagnosis. Using miRNAs as biomarkers for AIS diagnostics is especially relevant since miRNAs can serve for early diagnoses and for evaluating the positive effects of applied therapies to therefore reduce the need of high-risk surgical interventions.
Conflict of interest statement
J.L.G.G., S.M.M., D.H., T.B. and F.V.P.C. are inventors of this method with application reference: PCT/EP2016/063935. J.L.G.G. and S.M.M. are currently the C.E.O. and C.S.O. of EpiDisease S.L., respectively. EpiDisease is a Spin-Off of the Center for Biomedical Network Research on Rare Diseases (Spanish Institute of Health Instituto de Salud Carlos III), the Biomedical Research Center INCLIVA and the University of Valencia. P.R.B., L.P.C., E.M.G.L., D.G.R., J.S.I.C. and P.B.H. report no conflicts of interest.
Figures
References
- Konieczny MR, Senyurt H, Krauspe R. Epidemiology of adolescent idiopathic scoliosis. Journal of children’s orthopaedics. 2013;7:3–9. doi: 10.1007/s11832-012-0457-4.
- Moreau, C. J. K. M.-Y. A. A. Towards a Comprehensive Diagnostic Assay for Scoliosis. Personalized Medicine10, doi:10.2217/PME.12.117 (2013).
- Cheng JC, et al. Adolescent idiopathic scoliosis. Nature reviews. Disease primers. 2015;1:15030. doi: 10.1038/nrdp.2015.30.
- Gorman KF, Julien C, Moreau A. The genetic epidemiology of idiopathic scoliosis. Eur Spine J. 2012;21:1905–1919. doi: 10.1007/s00586-012-2389-6.
- Ikegawa S. Genomic study of adolescent idiopathic scoliosis in Japan. Scoliosis and spinal disorders. 2016;11:5. doi: 10.1186/s13013-016-0067-x.
- Zhu Z, Xu L, Qiu Y. Current progress in genetic research of adolescent idiopathic scoliosis. Annals of translational medicine. 2015;3:S19.
- Burwell RG, Dangerfield PH, Moulton A, Grivas TB. Adolescent idiopathic scoliosis (AIS), environment, exposome and epigenetics: a molecular perspective of postnatal normal spinal growth and the etiopathogenesis of AIS with consideration of a network approach and possible implications for medical therapy. Scoliosis. 2011;6:26. doi: 10.1186/1748-7161-6-26.
- Garcia-Gimenez JL, et al. Epigenetic biomarkers: A new perspective in laboratory diagnostics. Clinica chimica acta; international journal of clinical chemistry. 2012;413:1576–1582. doi: 10.1016/j.cca.2012.05.021.
- Sandoval J, Peiro-Chova L, Pallardo FV, Garcia-Gimenez JL. Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities. Expert review of molecular diagnostics. 2013;13:457–471. doi: 10.1586/erm.13.37.
- Keller A, et al. Toward the blood-borne miRNome of human diseases. Nature methods. 2011;8:841–843. doi: 10.1038/nmeth.1682.
- Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer science. 2010;101:2087–2092. doi: 10.1111/j.1349-7006.2010.01650.x.
- Peiro-Chova L, et al. High stability of microRNAs in tissue samples of compromised quality. Virchows Archiv: an international journal of pathology. 2013;463:765–774. doi: 10.1007/s00428-013-1485-2.
- Garcia-Gimenez, J. L. Epigenetic Biomarkers and Diagnostics. Vol. 1 (Academic Press, 2015).
- Lian JB, et al. MicroRNA control of bone formation and homeostasis. Nature reviews. Endocrinology. 2012;8:212–227. doi: 10.1038/nrendo.2011.234.
- Deurloo JA, Verkerk PH. To screen or not to screen for adolescent idiopathic scoliosis? A review of the literature. Public health. 2015;129:1267–1272. doi: 10.1016/j.puhe.2015.07.021.
- Buchan JG, et al. Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. Human molecular genetics. 2014;23:5271–5282. doi: 10.1093/hmg/ddu224.
- Londono D, et al. A meta-analysis identifies adolescent idiopathic scoliosis association with LBX1 locus in multiple ethnic groups. Journal of medical genetics. 2014;51:401–406. doi: 10.1136/jmedgenet-2013-102067.
- Ryzhkov II, et al. Transforming growth factor beta 1 is a novel susceptibility gene for adolescent idiopathic scoliosis. Spine (Phila Pa 1976) 2013;38:E699–704. doi: 10.1097/BRS.0b013e31828de9e1.
- Zhu Z, et al. Genome-wide association study identifies novel susceptible loci and highlights Wnt/beta-catenin pathway in the development of adolescent idiopathic scoliosis. Human molecular genetics. 2017;26:1577–1583. doi: 10.1093/hmg/ddx045.
- Liu XY, Wang L, Yu B, Zhuang QY, Wang YP. Expression Signatures of Long Noncoding RNAs in Adolescent IdiopathicScoliosis. BioMed research international. 2015;2015:276049.
- Sun ZJ, et al. Identification of candidate diagnostic biomarkers for adolescent idiopathic scoliosis using UPLC/QTOF-MS analysis: a first report of lipid metabolism profiles. Scientific reports. 2016;6:22274. doi: 10.1038/srep22274.
- Knott P, et al. SOSORT 2012 consensus paper: reducing x-ray exposure in pediatric patients with scoliosis. Scoliosis. 2014;9:4. doi: 10.1186/1748-7161-9-4.
- Ronckers CM, et al. Cancer mortality among women frequently exposed to radiographic examinations for spinal disorders. Radiat Res. 2010;174:83–90. doi: 10.1667/RR2022.1.
- Simony A, Hansen EJ, Christensen SB, Carreon LY, Andersen MO. Incidence of cancer in adolescent idiopathic scoliosis patients treated 25 years previously. Eur Spine J. 2016;25:3366–3370. doi: 10.1007/s00586-016-4747-2.
- Cédric Julien KFG, Akoume M-Y, Towards AM. a Comprehensive Diagnostic Assay for Scoliosis. Personalized Medicine. 2013;10:97–103. doi: 10.2217/pme.12.117.
- Hsu SD, et al. miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 2014;42:D78–85. doi: 10.1093/nar/gkt1266.
- Liu B, Li J, Cairns MJ. Identifying miRNAs, targets and functions. Briefings in bioinformatics. 2014;15:1–19. doi: 10.1093/bib/bbs075.
- Wang G, Zhao Y, Zheng Y. MiR-122/Wnt/beta-catenin regulatory circuitry sustains glioma progression. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35:8565–8572. doi: 10.1007/s13277-014-2089-4.
- Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem. 2005;280:41342–41351. doi: 10.1074/jbc.M502168200.
- Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013;19:179–192. doi: 10.1038/nm.3074.
- Wang T, Xu Z. miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochemical and biophysical research communications. 2010;402:186–189. doi: 10.1016/j.bbrc.2010.08.031.
- Abe E, et al. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res. 2000;15:663–673. doi: 10.1359/jbmr.2000.15.4.663.
- Kang Q, et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev. 2009;18:545–559. doi: 10.1089/scd.2008.0130.
- Gong Y, et al. MicroRNA expression signature for Satb2-induced osteogenic differentiation in bone marrow stromal cells. Mol Cell Biochem. 2014;387:227–239. doi: 10.1007/s11010-013-1888-z.
- Fei Y, Xiao L, Doetschman T, Coffin DJ, Hurley MM. Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the Wnt signaling pathway. J Biol Chem. 2011;286:40575–40583. doi: 10.1074/jbc.M111.274910.
- Agas D, Sabbieti MG, Marchetti L, Xiao L, Hurley MM. FGF-2 enhances Runx-2/Smads nuclear localization in BMP-2 canonical signaling in osteoblasts. J Cell Physiol. 2013;228:2149–2158. doi: 10.1002/jcp.24382.
- Zhang HW, et al. Defects in mesenchymal stem cell self-renewal and cell fate determination lead to an osteopenic phenotype in Bmi-1 null mice. J Bone Miner Res. 2010;25:640–652. doi: 10.1359/jbmr.090812.
- Sugatani T, Hruska KA. MicroRNA-223 is a key factor in osteoclast differentiation. Journal of cellular biochemistry. 2007;101:996–999. doi: 10.1002/jcb.21335.
- Chen G, Deng C, Li YP. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci. 2012;8:272–288. doi: 10.7150/ijbs.2929.
- Wang ST, et al. Expression and correlation of Lewis y antigen and TGF-beta1 in ovarian epithelial carcinoma. Oncology reports. 2012;27:1065–1071. doi: 10.3892/or.2011.1575.
- Karsenty G, Kronenberg HM, Settembre C. Genetic control of bone formation. Annu Rev Cell Dev Biol. 2009;25:629–648. doi: 10.1146/annurev.cellbio.042308.113308.
- Komori T. Regulation of osteoblast differentiation by transcription factors. Journal of cellular biochemistry. 2006;99:1233–1239. doi: 10.1002/jcb.20958.
- Itokowa T, et al. Osteoclasts lacking Rac2 have defective chemotaxis and resorptive activity. Calcif Tissue Int. 2011;88:75–86. doi: 10.1007/s00223-010-9435-3.
- Tabas JA, et al. Bone morphogenetic protein: chromosomal localization of human genes for BMP1, BMP2A, and BMP3. Genomics. 1991;9:283–289. doi: 10.1016/0888-7543(91)90254-C.
- Papaioannou G, Mirzamohammadi F, Kobayashi T. MicroRNAs involved in bone formation. Cellular and molecular life sciences: CMLS. 2014;71:4747–4761. doi: 10.1007/s00018-014-1700-6.
- Millner PA, Dickson RA. Idiopathic scoliosis: biomechanics and biology. Eur Spine J. 1996;5:362–373. doi: 10.1007/BF00301963.
- Bonewald LF, Johnson ML. Osteocytes, mechanosensing and Wnt signaling. Bone. 2008;42:606–615. doi: 10.1016/j.bone.2007.12.224.
- Ozcivici E, et al. Mechanical signals as anabolic agents in bone. Nat Rev Rheumatol. 2010;6:50–59. doi: 10.1038/nrrheum.2009.239.
- Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature. 2003;423:349–355. doi: 10.1038/nature01660.
- Yim AP, et al. Abnormal skeletal growth patterns in adolescent idiopathic scoliosis–a longitudinal study until skeletal maturity. Spine (Phila Pa 1976) 2012;37:E1148–1154. doi: 10.1097/BRS.0b013e31825c036d.
- Newton Ede MM, Jones SW. Adolescent idiopathic scoliosis: evidence for intrinsic factors driving aetiology and progression. International orthopaedics. 2016;40:2075–2080. doi: 10.1007/s00264-016-3132-4.
- Ochi K, et al. Use of isolated mature osteoblasts in abundance acts as desired-shaped bone regeneration in combination with a modified poly-DL-lactic-co-glycolic acid (PLGA)-collagen sponge. J Cell Physiol. 2003;194:45–53. doi: 10.1002/jcp.10185.
- Eskildsen T, et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA. 2011;108:6139–6144. doi: 10.1073/pnas.1016758108.
- Eguchi T, et al. OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells. PLoS One. 2013;8:e58796. doi: 10.1371/journal.pone.0058796.
- Ell B, Kang Y. MicroRNAs as regulators of bone homeostasis and bone metastasis. Bonekey Rep. 2014;3:549. doi: 10.1038/bonekey.2014.44.
- Valenti, M. T., Dalle Carbonare, L. & Mottes, M. Osteogenic Differentiation in Healthy and Pathological Conditions. International journal of molecular sciences18, doi:10.3390/ijms18010041 (2016).
- Chowanska J, Kotwicki T, Rosadzinski K, Sliwinski Z. School screening for scoliosis: can surface topography replace examination with scoliometer? Scoliosis. 2012;7:9. doi: 10.1186/1748-7161-7-9.
- Oh CH, et al. Usefulness of chest radiographs for scoliosis screening: a comparison with thoraco-lumbar standing radiographs. Yonsei Med J. 2012;53:1183–1189. doi: 10.3349/ymj.2012.53.6.1183.
- Mizuno Y, et al. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett. 2009;583:2263–2268. doi: 10.1016/j.febslet.2009.06.006.
- Nair R, et al. Extracellular vesicles derived from preosteoblasts influence embryonic stem cell differentiation. Stem Cells Dev. 2014;23:1625–1635. doi: 10.1089/scd.2013.0633.
- Cao Y, Min J, Zhang Q, Li H, Li H. Associations of LBX1 gene and adolescent idiopathic scoliosis susceptibility: a meta-analysis based on 34,626 subjects. BMC musculoskeletal disorders. 2016;17:309. doi: 10.1186/s12891-016-1139-z.
- Zhu Z, et al. Genome-wide association study identifies new susceptibility loci for adolescent idiopathic scoliosis in Chinese girls. Nature communications. 2015;6:8355. doi: 10.1038/ncomms9355.
- Lin Q, Gao Z, Alarcon RM, Ye J, Yun Z. A role of miR-27 in the regulation of adipogenesis. The FEBS journal. 2009;276:2348–2358. doi: 10.1111/j.1742-4658.2009.06967.x.
- Sugatani T, Hruska KA. Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem. 2009;284:4667–4678. doi: 10.1074/jbc.M805777200.
- Fazi F, et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell. 2005;123:819–831. doi: 10.1016/j.cell.2005.09.023.
- DiLeone RJ, et al. The Bmp8 gene is expressed in developing skeletal tissue and maps near the Achondroplasia locus on mouse chromosome 4. Genomics. 1997;40:196–198. doi: 10.1006/geno.1996.4533.
- Paraskevopoulou MD, et al. DIANA-microT web serverv5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res. 2013;41:W169–173. doi: 10.1093/nar/gkt393.
- Vlachos IS, et al. DIANA-miRPathv3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015;43:W460–466. doi: 10.1093/nar/gkv403.
- Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:R106. doi: 10.1186/gb-2010-11-10-r106.
- Breiman L. Random Forests. Machine learning. 2001;45:5–32. doi: 10.1023/A:1010933404324.
- Robinson MD, Smyth GK. Moderated statistical tests for assessing differences in tag abundance. Bioinformatics. 2007;23:2881–2887. doi: 10.1093/bioinformatics/btm453.
- Hosmer, D. W., Lemeshow S., and Sturdivant, Rodney X. Applied Logistic Regression. (John Wiley & Sons, Inc., 2013).
- Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq. 2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.
Source: PubMed